Dr Alfredo L Marti, MD | |
1001 12th Ave Ste 170, Fort Worth, TX 76104-3926 | |
(817) 810-0500 | |
Not Available |
Full Name | Dr Alfredo L Marti |
---|---|
Gender | Male |
Speciality | Pain Management |
Experience | 42 Years |
Location | 1001 12th Ave Ste 170, Fort Worth, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1407806326 | NPI | - | NPPES |
137587512 | Medicaid | TX |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208VP0000X | Pain Medicine - Pain Medicine | J1722 (Texas) | Primary |
207L00000X | Anesthesiology | J1722 (Texas) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Baylor Scott & White All Saints Medical Center Fort Worth | Fort worth, TX | Hospital |
Texas Health Huguley Hospital Fort Worth South | Burleson, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Lone Star Orthopaedic And Spine Specialists, Pllc | 5597844951 | 16 |
News Archive
Heritage Provider Network, the nation's leading physicians' organization, is pleased to announce that seventeen organizations are now using its internally developed software suit of care coordination tools known as "QHMO." The organizations utilizing the suite of software products include leading hospital systems, a number of health plans, as well as a number of other physicians' organizations.
Endologix, Inc., developer of minimally invasive treatments for aortic disorders, announced today that TechAmerica has named Endologix as Orange County's Outstanding Company in Medical Technology. The award was presented to Endologix at the 17th Annual TechAmerica High-Tech Innovation Awards on June 2, 2010 in Irvine, CA.
Eli Lilly and Company today announced that the Centers for Medicare & Medicaid Services (CMS) has issued a draft decision proposing Coverage with Evidence Development for the use of beta-amyloid positron emission tomography (PET) imaging agents. Beta-amyloid imaging agents are used to evaluate patients with cognitive impairment for Alzheimer's Disease and other causes of cognitive decline.
One of cancer's most frightening characteristics is its ability to return after treatment. In the case of many forms of cancer, including the skin cancer known as melanoma, tailored drugs can eradicate cancer cells in the lab, but often produce only partial, temporary responses in patients. One of the burning questions in the field of cancer research has been and remains: how does cancer evade drug treatment?
At a median follow-up of 10.9 years, an EORTC study has shown that irradiation of regional nodes in patients with stage I, II, or III breast cancer has a marginal effect on overall survival, the primary endpoint (at 10 years, overall survival was 82.3 % for regional irradiation versus 80.7% for no regional irradiation, (HR=0.87 (95%CI: 0.76, 1.00), p=0.06).
› Verified 8 days ago
Entity Name | Medical Centre Pain Management Associates P A |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1902855521 PECOS PAC ID: 7810898509 Enrollment ID: O20040115001028 |
News Archive
Heritage Provider Network, the nation's leading physicians' organization, is pleased to announce that seventeen organizations are now using its internally developed software suit of care coordination tools known as "QHMO." The organizations utilizing the suite of software products include leading hospital systems, a number of health plans, as well as a number of other physicians' organizations.
Endologix, Inc., developer of minimally invasive treatments for aortic disorders, announced today that TechAmerica has named Endologix as Orange County's Outstanding Company in Medical Technology. The award was presented to Endologix at the 17th Annual TechAmerica High-Tech Innovation Awards on June 2, 2010 in Irvine, CA.
Eli Lilly and Company today announced that the Centers for Medicare & Medicaid Services (CMS) has issued a draft decision proposing Coverage with Evidence Development for the use of beta-amyloid positron emission tomography (PET) imaging agents. Beta-amyloid imaging agents are used to evaluate patients with cognitive impairment for Alzheimer's Disease and other causes of cognitive decline.
One of cancer's most frightening characteristics is its ability to return after treatment. In the case of many forms of cancer, including the skin cancer known as melanoma, tailored drugs can eradicate cancer cells in the lab, but often produce only partial, temporary responses in patients. One of the burning questions in the field of cancer research has been and remains: how does cancer evade drug treatment?
At a median follow-up of 10.9 years, an EORTC study has shown that irradiation of regional nodes in patients with stage I, II, or III breast cancer has a marginal effect on overall survival, the primary endpoint (at 10 years, overall survival was 82.3 % for regional irradiation versus 80.7% for no regional irradiation, (HR=0.87 (95%CI: 0.76, 1.00), p=0.06).
› Verified 8 days ago
Entity Name | Lone Star Orthopaedic And Spine Specialists, Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1134398217 PECOS PAC ID: 5597844951 Enrollment ID: O20080509000481 |
News Archive
Heritage Provider Network, the nation's leading physicians' organization, is pleased to announce that seventeen organizations are now using its internally developed software suit of care coordination tools known as "QHMO." The organizations utilizing the suite of software products include leading hospital systems, a number of health plans, as well as a number of other physicians' organizations.
Endologix, Inc., developer of minimally invasive treatments for aortic disorders, announced today that TechAmerica has named Endologix as Orange County's Outstanding Company in Medical Technology. The award was presented to Endologix at the 17th Annual TechAmerica High-Tech Innovation Awards on June 2, 2010 in Irvine, CA.
Eli Lilly and Company today announced that the Centers for Medicare & Medicaid Services (CMS) has issued a draft decision proposing Coverage with Evidence Development for the use of beta-amyloid positron emission tomography (PET) imaging agents. Beta-amyloid imaging agents are used to evaluate patients with cognitive impairment for Alzheimer's Disease and other causes of cognitive decline.
One of cancer's most frightening characteristics is its ability to return after treatment. In the case of many forms of cancer, including the skin cancer known as melanoma, tailored drugs can eradicate cancer cells in the lab, but often produce only partial, temporary responses in patients. One of the burning questions in the field of cancer research has been and remains: how does cancer evade drug treatment?
At a median follow-up of 10.9 years, an EORTC study has shown that irradiation of regional nodes in patients with stage I, II, or III breast cancer has a marginal effect on overall survival, the primary endpoint (at 10 years, overall survival was 82.3 % for regional irradiation versus 80.7% for no regional irradiation, (HR=0.87 (95%CI: 0.76, 1.00), p=0.06).
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Alfredo L Marti, MD 215 Old Highway 1187, Burleson, TX 76028-0281 Ph: (817) 926-2663 | Dr Alfredo L Marti, MD 1001 12th Ave Ste 170, Fort Worth, TX 76104-3926 Ph: (817) 810-0500 |
News Archive
Heritage Provider Network, the nation's leading physicians' organization, is pleased to announce that seventeen organizations are now using its internally developed software suit of care coordination tools known as "QHMO." The organizations utilizing the suite of software products include leading hospital systems, a number of health plans, as well as a number of other physicians' organizations.
Endologix, Inc., developer of minimally invasive treatments for aortic disorders, announced today that TechAmerica has named Endologix as Orange County's Outstanding Company in Medical Technology. The award was presented to Endologix at the 17th Annual TechAmerica High-Tech Innovation Awards on June 2, 2010 in Irvine, CA.
Eli Lilly and Company today announced that the Centers for Medicare & Medicaid Services (CMS) has issued a draft decision proposing Coverage with Evidence Development for the use of beta-amyloid positron emission tomography (PET) imaging agents. Beta-amyloid imaging agents are used to evaluate patients with cognitive impairment for Alzheimer's Disease and other causes of cognitive decline.
One of cancer's most frightening characteristics is its ability to return after treatment. In the case of many forms of cancer, including the skin cancer known as melanoma, tailored drugs can eradicate cancer cells in the lab, but often produce only partial, temporary responses in patients. One of the burning questions in the field of cancer research has been and remains: how does cancer evade drug treatment?
At a median follow-up of 10.9 years, an EORTC study has shown that irradiation of regional nodes in patients with stage I, II, or III breast cancer has a marginal effect on overall survival, the primary endpoint (at 10 years, overall survival was 82.3 % for regional irradiation versus 80.7% for no regional irradiation, (HR=0.87 (95%CI: 0.76, 1.00), p=0.06).
› Verified 8 days ago
Thomas M. Ratino, M.D. Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1307 8th Ave.,, Suite 506, Fort Worth, TX 76104 Phone: 817-332-6092 Fax: 817-332-6015 | |
Tim Paul Ratino, M.D. Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1307 8th Ave Ste 506, Fort Worth, TX 76104 Phone: 817-332-6092 Fax: 817-332-6015 | |
Vinay Dalal, MD Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 413 West Rosedale, Fort Worth, TX 76104 Phone: 817-348-8082 Fax: 817-348-8772 | |
Krishna Luitel, PA-C Pain Medicine Medicare: Medicare Enrolled Practice Location: 416 S Henderson St, Fort Worth, TX 76104 Phone: 682-478-8123 Fax: 888-851-5356 | |
Dr. Kent Mitchell, M.D. Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 Lipscomb St Ste 110, Fort Worth, TX 76104 Phone: 817-348-8600 Fax: 817-348-8602 | |
Dr. Ashley M Classen, D.O. Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 823 Pennsylvania Ave, Fort Worth, TX 76104 Phone: 817-332-3664 Fax: 817-882-9888 |